Omberacetam (also known as Noopept or GVS-111) is a synthetic nootropic dipeptide (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia in 1996 for its potent cognitive-enhancing and…
View researchOrforglipron (brand name Foundayo) is an FDA-approved oral, non-peptide GLP-1 receptor agonist and the first small-molecule GLP-1 approved for weight management.
View researchOvagen is a synthetic tripeptide with the sequence Glu-Asp-Leu (EDL), developed by Vladimir Kh.
View researchOxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary.
View researchP21 (also known as P021) is a synthetic tetrapeptide derived from the biologically active region of human ciliary neurotrophic factor (CNTF).
View researchPE-22-28, also known as Mini-Spadin, is a synthetic heptapeptide derived from positions 22-28 of the parent peptide Spadin.
View researchPEG-MGF (Pegylated Mechano Growth Factor) is a modified form of the IGF-1 splice variant MGF (IGF-1Ec), with polyethylene glycol attached to extend its half-life from minutes to hours.
View researchPinealon (Glu-Asp-Arg/EDR) is a synthetic tripeptide bioregulator developed in Russia that demonstrates unique DNA-interaction capabilities for neuroprotection and cognitive enhancement.
View researchPNC-27 is a 32-amino acid chimeric anticancer peptide developed in 2000 by Dr.
View researchProstamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects.
View researchPT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system.
View researchRetatrutide (LY3437943) is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors.
View research